Belite Bio (BLTE) Selling, General & Administrative (2022 - 2026)
Belite Bio (BLTE) Selling, General & Administrative (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn | -166.00 Mn |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - | 2.17 Mn |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn | 555.10 Mn |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn | 493.70 Mn |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn | -15.22 Mn |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn | -355.00 Mn |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn | 322.55 Mn |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - | 101.25 Mn |
| 10 | Belite Bio | 96.77 Mn | 96.77 Mn | - | 17.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.02 Mn |
| Dec 31, 2025 | 13.45 Bn |
| Sep 30, 2025 | 12.71 Bn |
| Jun 30, 2025 | 6.55 Bn |
| Mar 31, 2025 | 6.12 Mn |
| Dec 31, 2024 | 4.20 Bn |
| Sep 30, 2024 | 2.90 Bn |
| Jun 30, 2024 | 1.39 Bn |
| Mar 31, 2024 | 1.56 Bn |
| Dec 31, 2023 | 2.09 Mn |
| Sep 30, 2023 | 2.22 Mn |
| Jun 30, 2023 | 1.36 Bn |
| Mar 31, 2023 | 1.16 Bn |
| Dec 31, 2022 | 1.50 Mn |
| Sep 30, 2022 | 1.36 Bn |
| Jun 30, 2022 | 927.00 Mn |